Skip to main content

Table 3 Overall and disease-free survival analyses according to different times to decision and time-to-surgery cut-offs

From: Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma

Cut-off

Number of patients

Overall survival

Disease-free survival

Lower cut-off

Higher cut-off

p

OR

CI 95%

p

OR

CI 95%

Univariate analysis

        

 Time to decision

        

  ≤ 7 days vs. > 7 days

18

147

0.59

0.89

0.57–1.38

0.56

0.88

0.58–1.34

  ≤ 14 days vs. > 14 days

59

106

0.50

0.86

0.55–1.34

0.56

0.88

0.58–1.34

  ≤ 28 days vs. > 28 days

104

61

0.79

1.07

0.65–1.76

0.68

1.10

0.69–1.8

  ≤ 60 days vs. > 60 days

151

14

0.78

0.88

0.35–2.19

0.79

1.09

0.6–1.97

  ≤ 7 days vs. > 28 days

18

61

0.96

0.98

0.58–1.68

0.97

1.01

0.61–1.68

 Time to surgery

        

  ≤ 7 days vs. > 7 days

18

147

0.21

1.43

0.82–2.52

0.22

1.4

0.81–2.41

  ≤ 14 days vs. > 14 days

59

106

0.97

0.99

0.67–1.46

0.82

0.95

0.66–1.39

  ≤ 28 days vs. > 28 days

104

61

0.38

1.2

0.80–1.77

0.33

1.21

0.83–1.76

  ≤ 60 days vs. > 60 days

151

14

0.88

0.95

0.52–1.74

0.79

1.09

0.6–1.97

  ≤ 75 days vs. > 75 days

157

8

0.84

0.93

0.3–1.99

0.88

1.06

0.49–2.28

  ≤ 7 days vs. > 60 days

18

14

0.34

1.5

0.66–3.41

0.26

1.6

0.71–3.59

Multivariate analysisa

        

 Time to surgery

        

  ≤ 14 days vs. > 14 days

59

104

0.44

1.18

0.76–1.82

0.99

1.00

0.66–1.51

  1. vs versus; OR odds ratio; CI 95% confidence interval 95%
  2. aAdjusted analysis for vein resection, jaundice, and hemorrhage